Login / Signup

Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases.

Zheng YanShuna YaoJunhui YuanYanyan LiuZhihua Yao
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Multiple rechallenges with immunotherapy is feasible in selected patients with rCIP.
Keyphrases
  • dna damage
  • idiopathic pulmonary fibrosis
  • drug induced